Eiger BioPharmaceuticals, Inc. (EIGR) Discounted Future Market Cap - Discounting Cash Flows
Eiger BioPharmaceuticals, Inc.
EIGR (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 1.85 USD
Estimated net income -143 Mil. USD
Estimated market capitalization 4.87 Mil. USD
Market capitalization discounted to present 2.73 Mil. USD
Shares Outstanding 1.48 Mil.
Earnings Per Share (EPS) -50.81 USD
Market Price 1.73 USD
Price to Earnings (PE) Ratio -0.167

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue
15.77 17.38 19.82 22.59 25.76 29.37
Revenue Growth Rate
14.01% 14.01% 14.01% 14.01%
Net Income
-74.96 -84.64 -96.49 -110 -125.4 -143

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 14.29 15.77
15.77 13.48 12.14 0 0 0 0 0 0
Cost of Revenue 0.451 0.644
0.024 1.84 0.745 0.645 0.486 0.054 0.041 0.023 0.011
Gross Profit 5.27 15.13
15.75 11.65 11.4 -0.645 -0.486 -0.054 -0.041 -0.023 -0.011
Gross Margin 94% 95.92%
99.85% 86.38% 93.86%
Operating Income -62.52 -71.79
-71.79 -92.74 -76.94 -62.15 -68.9 -51.05 -41.52 -46.12 -42.18
Operating Margin -557.9% -455.1%
-455.1% -687.8% -633.7%
Net Income -60.92 -74.96
-74.96 -96.78 -33.92 -68.63 -73.64 -52.39 -42.45 -47.09 -44.41
Net Margin -486.9% -475.3%
-475.3% -717.7% -279.3%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 14.29 15.77
15.77 13.48 12.14 0 0 0 0 0 0
Revenue Growth Rate 14.02%
16.98% 11.05%
Net Income -60.92 -74.96
-74.96 -96.78 -33.92 -68.63 -73.64 -52.39 -42.45 -47.09 -44.41
Net Margin -486.9% -475.3%
-475.3% -717.7% -279.3%
Net Income Growth Rate 21.86%
-22.54% 185.3% -50.58% -6.8% 40.56% 23.42% -9.85% 6.02% 31.19%
Stockholders Equity 41.17 -14.46
-14.46 55.31 72.4 95.03 56.48 66.59 22.52 40.72 31.55
Equity Growth Rate 0.376%
-126.1% -23.6% -23.82% 68.26% -15.19% 195.7% -44.69% 29.06% -56.24%
Return on Invested Capital (ROIC) 206.4% 179.5%
179.9% -134% -103.8% -66.84% -148% -166.9% -1,206% -167.9% 3,698%
After-tax Operating Income -63.71 -71.6
-71.79 -92.76 -77.08 -65.57 -72.23 -52.01 -43.15 -46.5 -44.37
Income Tax Rate -2.21% 0.256%
-0.008% -0.024% -0.189% -5.51% -4.83% -1.88% -3.93% -0.828% -5.19%
Invested Capital 27.19 -39.9
-39.9 69.22 74.28 98.1 48.82 31.16 3.58 27.69 -1.2
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us